EUVIMEDEUVIMED entdecken
Crossref

Examination of Excessive Mind-Wandering Following Attention-Deficit and Hyperactivity Disorder Treatment in Adults

Uğur Takım iD, Hasan Gökçay iD

Psychological Reports · 2025

DOI: 10.1177/00332941241281816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychological Reports, 2025. Verfasst von Uğur Takım und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Methylphenidate, Atomoxetine Hydrochloride, Central Nervous System Stimulants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although mind-wandering (MW) is a part of attention deficit and hyperactivity disorder (ADHD), the impact of psychostimulants on excessive MW remains unclear. We aimed to elucidate how psychostimulants impact the MW of adult ADHD patients post treatment. This cross-sectional cohort study consisted of 54 randomly selected ADHD patients who applied to our psychiatry outpatient clinic and 40 healthy controls. The ADHD patients were administered methylphenidate or atomoxetine. A Semi-Structured Sociodemographic and Clinical Data Form, the Adult ADHD Self-Report Scale (ASRS), and the Mind Excessively Wandering Scale (MEWS) were applied. Routine psychiatric assessments in the 1st, 2nd, and 3rd months of pharmacological treatment were carried out by a psychiatrist. The pre-treatment MEWS score of the ADHD patients was 26.09 ± 1.92, which significantly decreased to 12.78 ± 2.54 post-treatment (F = 715.250, p < .001). A statistically significant difference was identified between the mean pre-treatment ASRS total score (44.07 ± 10.09) and post-treatment score (27.34 ± 11.22; F = 50.364, p < .001). A lifetime history of alcohol/substance use was positively associated with the MEWS score. ADHD pharmacotherapy led to significant reductions in MW. Recognizing the interaction between MW and ADHD could help in the design of more specific and comprehensive interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityMethylphenidateAtomoxetine HydrochlorideCentral Nervous System StimulantsHumansAdultMaleFemaleCross-Sectional StudiesYoung AdultMiddle Aged

Stichwörter der Autor:innen

Attention-deficit/hyperactivity disordercognitive functionsexcessive mind-wanderingpsychostimulants

Substanzen

MethylphenidateAtomoxetine HydrochlorideCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Psychiatry, University of Health Sciences, Erzurum City Hospital, Erzurum, Turkey.
  • Department of Psychiatry, Sarkisla State Hospital, Sivas, Turkey.

ORCID-Profile: Uğur Takım, Hasan Gökçay

Zitieren

APA

Takım, U., & Gökçay, H. (2025). Examination of Excessive Mind-Wandering Following Attention-Deficit and Hyperactivity Disorder Treatment in Adults. Psychological Reports. https://doi.org/10.1177/00332941241281816

Vancouver

Takım U, Gökçay H. Examination of Excessive Mind-Wandering Following Attention-Deficit and Hyperactivity Disorder Treatment in Adults. Psychological Reports. 2025. doi:10.1177/00332941241281816

BibTeX
@article{Takm2025,
  author = {Takım, Uğur and Gökçay, Hasan},
  title = {Examination of Excessive Mind-Wandering Following Attention-Deficit and Hyperactivity Disorder Treatment in Adults},
  journal = {Psychological Reports},
  year = {2025},
  doi = {10.1177/00332941241281816}
}
Kostenlos starten →